Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture

Ocular Immunology and Inflammation

Volumn 18, Issue 3, 2010, Pages 194-199

  Doycheva, Deshka ^a   Pfannenberg, Christina ^b   Hetzel, Juergen ^b   Deuter, Christoph M E ^a   Pavesio, Carlos ^c   Kempf, Volkhard A J ^b   Schuelen, Eva ^b   Aschoff, Philip ^b   Rao, Narsing ^d   Zierhut, Manfred ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Diagnosis; PET CT; Tuberculosis; Uveitis; Vasculitis

Indexed keywords

ACETAZOLAMIDE; ALPHA INTERFERON; ANTIGLAUCOMA AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BEVACIZUMAB; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STEROID; TUBERCULOSTATIC AGENT;

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; ASPIRATION BIOPSY; BACTERIUM CULTURE; BACTERIUM DETECTION; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; EYE INFLAMMATION; EYE PAIN; FLUORESCENCE ANGIOGRAPHY; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE ABNORMALITY; MALE; MYCOBACTERIUM TUBERCULOSIS; OCULAR TUBERCULOSIS; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; REMISSION; RETINA BLOOD VESSEL OCCLUSION; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VASCULITIS; TRANSBRONCHIAL ASPIRATION; VITRECTOMY; VITREOUS FLOATERS;

ADULT; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; FLUORESCEIN ANGIOGRAPHY; FLUORODEOXYGLUCOSE F18; FUNDUS OCULI; HUMANS; LYMPH NODES; MALE; MEDIASTINUM; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETINAL VASCULITIS; TUBERCULOSIS, OCULAR;

EID: 77952824716     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.483318     Document Type: Article

References (24)

1. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol. 1992;76:137-141.
2. Gupta V, Gupta A, Rao NA. Intraocular tuberculosis-an update. Surv Ophthalmol. 2007;52:561-587.
3. Rosen PH, Spalton DJ, Graham EM. Intraocular tuberculosis. Eye. 1990;4:486-492.
4. Chan HS, Pang J. Vasculitis in tuberculous infection. Chest. 1990;98:511.
5. Fountain JA, Werner RB. Tuberculous retinal vasculitis. Retina. 1984;4:48-50.
6. Gupta A, Gupta V, Arora S, et al. PCR-positive tubercular retinal vasculitis. Retina. 2001;21:435-444.
7. Glassroth J, Robins AG, Snider DE. Tuberculosis in the 1980s. N Engl J Med. 1980;302:1441-1450.
8. Kubota R, Kubota K, Yamada S, et al. Microautoradiolographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med. 1994;35:104-112.
9. Bybel B, Brunken RC, Shah SN, et al. PET and PET/CT imaging: what clinicians need to know. Clevl Clin J Med. 2006;73:1075-1087.
10. El-Haddad G, Zhuang H, Gupta N, Alavi A. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;172:519-521.
11. Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914-924.
12. Tannen BL, Ghesani NV, Frohman L, et al. Use of wholebody FDG PET-CT to aid in the diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2008;16:25-27.
13. Shulman JP, Latkany P, Cjin KJ, et al. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis. Ocul Immunol Inflamm. 2009;17: 95-100.
14. Seve P, Billotey C, Janier M, et al. Fluorodeoxyglucose positrone emission tomography for the dianosis of sarcoidosis in patients with unexplained chronic uveitis. Ocul Immunol Inflamm. 2009;17:179-184.
15. Dye C, Scheele S, Dolin P, et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677-686.
16. Orme IM. The latent tubercle bacillus (I'll let you know if I ever meet one). Int J Tuberc Lung Dis. 2001;5:589-593.
17. Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci. 2004;9:1136-1156.
18. Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculosis uveitis. Ocul Immunol Inflamm. 2009;17:351-355.
19. Kent DC, Houk VN, Elliott RC, et al. The definitive evaluation of sarcoidosis. Am Rev Respir Dis. 1970;101: 721-727.
20. Gupta D, Agarwal R, Agarwal AN, et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J. 2007;30:508-516.
21. Drake WP, Pei Z, Pride DT, et al. Molecular analysis of sarcoidosis tissues for Mycobacterium species DNA. Emerg Infect Dis. 2002;8:1334-1341.
22. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase- peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201:755-767.
23. Moller DR. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc. 2007;4:465-468.
24. Wakefield D, Zierhut M. Controversy: Ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18:5-9.